Cancer Biosimilar Monoclonal Antibodies market

adicionou um novo artigo Outro

2025-09-30 06:02:41 - Traduzir

According to a new report from Intel Market Research, the global Cancer Biosimilar Monoclonal Antibodies market was valued at USD 5,936 million in 2024 and is projected to reach USD 13,810 million by 2032, growing at a remarkable CAGR of 13.0% during the forecast period (2025–2032). This growth trajectory stems from increasing cancer prevalence, improved biosimilar acceptance, and patent...

0 Comentários 0 Compartilhamentos 98 Visualizações 0 Anterior